KBC Group NV »

Palvella Therapeutics Inc Ne shares owned by KBC Group NV

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by KBC Group NV from 13F filings

Historical chart of KBC Group NV investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by KBC Group NV

Quarter filed Position value Share count Share price at filing
2026-03-31 $28k 224 125.00

More positions owned by KBC Group NV

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Bank of America Corporation (BAC)
Citigroup Com New (C)
Gilead Sciences (GILD)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)

View all positions for KBC Group NV

Top funds holding Palvella Therapeutics Inc Ne

Suvretta Capital Management
First Light Asset Management
BVF
Frazier Life Sciences Management
BlackRock
Jennison Associates
Vanguard Group
Vanguard Capital Management
Federated Investors
State Street Corporation
Summit Partners Public Asset Management
Woodline Partners
Alliancebernstein
FMR
MPM Oncology Impact Management

View all funds holding Palvella Therapeutics Inc Ne